SenzaGen AB @senzagenab

Excited to announce that another CRO has been trained on SenzaGen's GARD technology platform and is offering GARDsk… https://t.co/473a0PlUTL

SenzaGen AB @senzagenab

Dr Joshua Schmidt is announced as presenter at the next #ASCCT & #ESTIV webinar on June 12 at 11:00 am EDT. This we… https://t.co/eGVG9G7XDD

SenzaGen AB @senzagenab

Happy to present our in vitro assay to test for respiratory sensitizers, GARDair, at the #ASCCT #ESTIV webinar on… https://t.co/hv2ffPmbCk

SenzaGen AB @senzagenab

We recently announced an order from a customer who previously evaluated us and then placed an order for a larger nu… https://t.co/WtmAeYfFzH

SenzaGen AB @senzagenab

Interested in the GARDskin ring trial performed for OECD validation? Read the full article now available ahead of p… https://t.co/KbfJJfquJP

SenzaGen AB @senzagenab

RT @EC_StockholmRep: Margaux Dietz besöker @SenzagenAb som utvecklar ny teknik för att testa allergiämnen, så att djurtester inte ska behöv…

SenzaGen AB @senzagenab

#Animalfree testing of #cosmeticproducts! Watch #margaux Dietz, one of Sweden´s most famous influencers, testing he… https://t.co/aXt32bkO9u

SenzaGen AB @senzagenab

Dr Andy Forreryd is announced as a speaker at the NVT Annual Meeting, Dutch Society of Toxicology in Ede, Holland o… https://t.co/WDhWrJEFGC

SenzaGen AB @senzagenab

See open link to the recorded SenzaGen GARD webinar presentation on Genomics and Machine learning for in vitro sens… https://t.co/mvQYC3u9Bg

SenzaGen AB @senzagenab

World Asthma Day May 7: To prevent and battle asthma, the EU has invested in SenzaGen’s GARD®air, the world's first… https://t.co/jJRRzlyz3z

SenzaGen AB @senzagenab

This study highlights toxicological risks associated with the undisclosed use of PPD in henna‐based natural “real‐l… https://t.co/uq4dilJVF4

SenzaGen AB @senzagenab

Spännande dag. Roligt att ha Margaux Dietz och hela teamet här! Tillsammans för bättre och säkrare produkter utan… https://t.co/wxI1IK5GuV

SenzaGen AB @senzagenab

80 people registered for today’s webinar session on Genomics and Machine Learning. Did you miss it? Sign up for tom… https://t.co/DSjUilAsdx

SenzaGen AB @senzagenab

The shareholders in SenzaGen AB is hereby summoned to the Annual General Meeting held on Wednesday May 15, 2019 at… https://t.co/vywXOAAQqo

SenzaGen AB @senzagenab

@CarlBorre, one of SenzaGen’s founders, presenting at Lund Grand Prix 2019 on new technologies for better health. S… https://t.co/thL9cOvsMn

SenzaGen AB @senzagenab

Only seven days remaining – reminder to register for the free webinar on April 17 or 18. A comprehensive explanatio… https://t.co/ul3MxDADgx

SenzaGen AB @senzagenab

Reminder - Don't miss this Invitation to free webinar on Genomics and Machine Learning #allyouneedtoknow #GARD #3Rs… https://t.co/kWBBPapjvM

SenzaGen AB @senzagenab

View presentation: CEO Anki Malmborg Hager explains how SenzaGen helps to drive the paradigm shift in toxicology te… https://t.co/uTCD6mZjIO

SenzaGen AB @senzagenab

Join our free webinar: Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro… https://t.co/9zx8l37vbc

SenzaGen AB @senzagenab

Join our free webinar Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro… https://t.co/ql8yWd43PV